Elite Pharmaceuticals (ELTP) Short Interest Ratio & Short Volume $0.69 +0.03 (+4.13%) As of 08/29/2025 03:59 PM Eastern Add Compare Share Share Short Interest Stock AnalysisChartEarningsHeadlinesSEC FilingsShort InterestBuy This Stock Elite Pharmaceuticals Short Interest DataElite Pharmaceuticals (ELTP) has a short interest of 2.48 million shares, representing 0.27% of the float (the number of shares available for trading by the public). This marks a 1.04% increase in short interest from the previous month. The short interest ratio (days to cover) is 1.6, indicating that it would take 1.6 days of the average trading volume of 1.70 million shares to cover all short positions.Current Short Interest2,475,200 sharesPrevious Short Interest2,449,800 sharesChange Vs. Previous Month+1.04%Dollar Volume Sold Short$1.26 millionShort Interest Ratio1.6 Days to CoverLast Record DateJuly 31, 2025Outstanding Shares1,070,860,000 sharesShort Percent of Float0.27%Today's Trading Volume7,560,003 sharesAverage Trading Volume1,695,661 sharesToday's Volume Vs. Average446% Short Selling Elite Pharmaceuticals? Sign up to receive the latest short interest report for Elite Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Get Report View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartELTP Short Interest Over TimeELTP Days to Cover Over TimeELTP Percentage of Float Shorted Over Time Elite Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/31/20252,475,200 shares $1.26 million +1.0%0.3%1.6 $0.51 7/15/20252,449,800 shares $1.30 million -4.9%N/A0.5 $0.53 6/30/20252,576,700 shares $1.89 million +11.2%0.3%0.4 $0.73 6/15/20252,317,200 shares $1.56 million +1.0%0.3%0.6 $0.67 5/31/20252,293,300 shares $1.24 million +17.0%0.3%1.4 $0.54 5/15/20251,960,500 shares $885.36 thousand -1.4%0.2%1.4 $0.45 4/30/20251,987,600 shares $822.07 thousand -0.1%N/A2.2 $0.41 4/15/20251,988,500 shares $845.91 thousand +1.0%0.2%0.7 $0.43 3/31/20251,968,400 shares $856.25 thousand -0.8%0.2%1.6 $0.44 3/15/20251,984,000 shares $960.06 thousand +0.1%0.2%1.7 $0.48 Get the Latest News and Ratings for ELTP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Elite Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 2/28/20251,982,000 shares $970.98 thousand -5.8%0.2%1 $0.49 2/15/20252,105,000 shares $1.12 million +3.6%0.2%0.8 $0.53 1/31/20252,031,600 shares $1.02 million +3.0%N/A1.3 $0.50 1/15/20251,972,500 shares $946.80 thousand -1.8%N/A0.6 $0.48 12/31/20242,008,300 shares $1.09 million -26.1%N/A0.8 $0.54 12/15/20242,717,700 shares $1.34 million +7.6%N/A0.9 $0.49 11/30/20242,526,500 shares $1.49 million +52.7%N/A0.5 $0.59 11/15/20241,654,500 shares $929.00 thousand +6.0%N/A0.4 $0.56 10/31/20241,560,500 shares $692.55 thousand -22.1%N/A0.1 $0.44 10/15/20242,004,100 shares $883.01 thousand -1.6%N/A0.6 $0.44 9/30/20242,036,000 shares $789.97 thousand -7.3%N/A0.6 $0.39 9/15/20242,195,500 shares $790.60 thousand +19.7%N/A0.2 $0.36 8/31/20241,834,800 shares $507.60 thousand +10.5%N/A0.3 $0.28 8/15/20241,661,100 shares $317.44 thousand +5.0%N/A1 $0.19 7/31/20241,581,500 shares $294.16 thousand -9.2%N/A1.4 $0.19 7/15/20241,740,800 shares $330.75 thousand +7.1%N/A1 $0.19 6/30/20241,625,700 shares $323.51 thousand +4.8%N/A1 $0.20 6/15/20241,550,800 shares $261.09 thousand -2.4%N/A2.4 $0.17 5/31/20241,588,700 shares $274.85 thousand +3.8%N/A1.3 $0.17 5/15/20241,530,700 shares $214.14 thousand -4.1%N/A1.3 $0.14 4/30/20241,595,900 shares $207.15 thousand -0.3%N/A1.8 $0.13 4/15/20241,601,300 shares $216.18 thousand +2.9%N/A1.4 $0.14 3/31/20241,555,700 shares $240.11 thousand -7.7%N/A1.4 $0.15 3/15/20241,684,700 shares $234.17 thousand +5.1%N/A0.9 $0.14 2/29/20241,602,900 shares $258.07 thousand +0.9%N/A0.4 $0.16 2/15/20241,588,800 shares $293.77 thousand +75.2%N/A0.5 $0.18 1/15/2024103,200 shares $18.01 thousand +24.8%N/A0 $0.17 12/31/202382,700 shares $11.58 thousand No ChangeN/A0 $0.14 11/30/202380,600 shares $11.08 thousand +58.4%N/A0 $0.14 11/15/202350,900 shares $7.38 thousand No ChangeN/A0 $0.15BREAKING: The House just passed 3 pro-crypto bills! (Ad)THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Discover the under-the-radar project I believe will skyrocket as a result. 10/15/2023228,000 shares $21.83 thousand +113.5%N/A0.3 $0.10 9/30/2023106,800 shares $10.02 thousand +862.2%N/A0.1 $0.09 9/15/202311,100 shares $865.80 -94.8%N/A0 $0.08 8/31/2023211,700 shares $18.63 thousand +1,283.7%N/A0 $0.09 8/15/202315,300 shares $711.45 -74.6%N/A0 $0.05 7/31/202360,300 shares $2.53 thousand +102.4%N/A0 $0.04 7/15/202329,800 shares $1.13 thousand No ChangeN/A0 $0.04 6/15/202311,000 shares $374.00 -7.6%N/A0 $0.03 5/31/202311,900 shares $367.71 +643.8%N/A0 $0.03 5/15/20231,600 shares $49.44 -85.7%N/A0 $0.03 4/30/202311,200 shares $369.60 +3,633.3%N/A0 $0.03 4/15/2023300 shares $9.30 -93.6%N/A0 $0.03 3/31/20234,700 shares $136.30 +193.8%N/A0 $0.03 3/15/20231,600 shares $50.40 -20.0%N/A0 $0.03 2/28/20232,000 shares $71.20 -95.5%N/A0 $0.04 2/15/202344,200 shares $1.70 thousand +44.9%N/A0.1 $0.04 1/31/202330,500 shares $1.03 thousand +74.3%N/A0 $0.03 1/15/202317,500 shares $525.00 +2,087.5%N/A0 $0.03 12/30/2022800 shares $23.60 +700.0%N/A0 $0.03 12/15/2022100 shares $3.00 -99.0%N/A0 $0.03 11/30/202210,000 shares $329.00 -54.3%N/A0 $0.03 11/15/202221,900 shares $755.55 +1,268.8%N/A0.1 $0.03 10/31/20221,600 shares $57.28 -96.3%N/A0 $0.04 10/15/202242,800 shares $1.33 thousand No ChangeN/A0 $0.03 9/15/2022400 shares $14.40 -99.4%N/A0 $0.04 8/31/202269,300 shares $2.48 thousand -2.8%N/A0 $0.04 8/15/202271,300 shares $3.21 thousand No ChangeN/A0.1 $0.05 7/15/20221,000 shares $42.90 -83.1%N/A0 $0.04 6/30/20225,900 shares $295.00 No ChangeN/A0 $0.05 5/31/20222,700 shares $123.39 No ChangeN/A0 $0.05 4/15/202216,900 shares $611.44 No ChangeN/A0 $0.04 2/28/2022212,900 shares $8.52 thousand +3,030.9%N/A0.2 $0.04 2/15/20226,800 shares $289.00 -89.5%N/A0 $0.04 1/31/202264,500 shares $2.55 thousand No ChangeN/A0.1 $0.04 12/31/2021100 shares $3.31 No ChangeN/A0 $0.03 12/15/2021100 shares $3.70 -99.6%N/A0 $0.04 11/30/202124,600 shares $883.14 +24,500.0%N/A0 $0.04 11/15/2021100 shares $3.82 -98.9%N/A0 $0.04 10/29/20219,400 shares $362.84 -38.2%N/A0 $0.04 10/15/202115,200 shares $608.00 +280.0%N/A0 $0.04 9/30/20214,000 shares $172.00 No ChangeN/A0 $0.04 8/31/202111,500 shares $543.95 +8.5%N/A0 $0.05 8/13/202110,600 shares $484.42 -46.7%N/A0 $0.05 7/30/202119,900 shares $953.21 +74.6%N/A0 $0.05 7/15/202111,400 shares $550.62 No ChangeN/A0 $0.05 6/15/202112,200 shares $668.56 No ChangeN/A0 $0.05 5/14/202121,600 shares $1.25 thousand +151.2%N/A0 $0.06 4/30/20218,600 shares $467.41 No ChangeN/A0 $0.05 3/31/20211,500 shares $87.00 -89.2%N/A0 $0.06 3/15/202113,900 shares $847.90 -65.6%N/A0 $0.06BREAKING: The House just passed 3 pro-crypto bills! (Ad)THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Discover the under-the-radar project I believe will skyrocket as a result. 2/26/202140,400 shares $2.59 thousand +1,054.3%N/A0 $0.06 2/12/20213,500 shares $261.80 +218.2%N/A0 $0.07 1/29/20211,100 shares $64.35 -83.3%N/A0 $0.06 12/31/202012,500 shares $675.00 No ChangeN/A0 $0.05 11/30/202027,400 shares $1.48 thousand -68.4%N/A0 $0.05 11/15/202086,700 shares $6.68 thousand No ChangeN/A0.1 $0.08 10/15/202012,100 shares $847.00 No ChangeN/A0 $0.07 8/31/202073,800 shares $5.83 thousand +939.4%N/A0 $0.08 ELTP Short Interest - Frequently Asked Questions What is Elite Pharmaceuticals' current short interest? Short interest is the volume of Elite Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of July 31st, traders have sold 2,475,200 shares of ELTP short. 0.27% of Elite Pharmaceuticals' shares are currently sold short. Learn More on Elite Pharmaceuticals' current short interest. What is a good short interest ratio for Elite Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ELTP shares currently have a short interest ratio of 2.0. Learn More on Elite Pharmaceuticals's short interest ratio. What is a good short interest percentage for Elite Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.27% of Elite Pharmaceuticals' floating shares are currently sold short. Is Elite Pharmaceuticals' short interest increasing or decreasing? Elite Pharmaceuticals saw a increase in short interest in July. As of July 31st, there was short interest totaling 2,475,200 shares, an increase of 1.0% from the previous total of 2,449,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Elite Pharmaceuticals' short interest compare to its competitors? 0.27% of Elite Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Elite Pharmaceuticals: Tarsus Pharmaceuticals, Inc. (21.18%), Centessa Pharmaceuticals PLC Sponsored ADR (5.10%), Agios Pharmaceuticals, Inc. (7.38%), ImmunityBio, Inc. (35.13%), IDEAYA Biosciences, Inc. (12.57%), Denali Therapeutics Inc. (10.21%), Harmony Biosciences Holdings, Inc. (9.66%), Ocular Therapeutix, Inc. (7.55%), Recursion Pharmaceuticals, Inc. (35.39%), Disc Medicine, Inc. (10.66%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.87 billion), Invesco QQQ ($30.12 billion), iShares Russell 2000 ETF ($19.85 billion), iShares 20+ Year Treasury Bond ETF ($10.34 billion), Strategy Inc ($8.98 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.61 billion), SPDR S&P Biotech ETF ($6.81 billion), Invesco S&P 500 Equal Weight ETF ($6.14 billion), Palo Alto Networks, Inc. ($5.97 billion), and Super Micro Computer, Inc. ($5.28 billion). View all of the most shorted stocks. What does it mean to sell short Elite Pharmaceuticals stock? Short selling ELTP is an investing strategy that aims to generate trading profit from Elite Pharmaceuticals as its price is falling. ELTP shares are trading up $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Elite Pharmaceuticals? A short squeeze for Elite Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ELTP, which in turn drives the price of the stock up even further. How often is Elite Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ELTP, twice per month. The most recent reporting period available is July, 31 2025. More Short Interest Resources from MarketBeat Related Companies Tarsus Pharmaceuticals Short Interest Centessa Pharmaceuticals Short Interest Agios Pharmaceuticals Short Interest ImmunityBio Short Interest IDEAYA Biosciences Short Interest Denali Therapeutics Short Interest Harmony Biosciences Short Interest Ocular Therapeutix Short Interest Recursion Pharmaceuticals Short Interest Disc Medicine Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:ELTP) was last updated on 8/31/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Elite Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Elite Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
